Matches in Nanopublications for { ?s ?p "[Overexpression of MN1, ERG, BAALC, and EVI1 (MEBE) genes in cytogenetically normal acute myeloid leukemia (AML) patients is associated with poor prognosis, but their prognostic effect in patients with myelodysplastic syndromes (MDS) has not been studied systematically.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- NP193508.RACuWyfVLgNIBPBugvpVlYtND_eT4qYlEdUFOGAxp-jP4130_assertion description "[Overexpression of MN1, ERG, BAALC, and EVI1 (MEBE) genes in cytogenetically normal acute myeloid leukemia (AML) patients is associated with poor prognosis, but their prognostic effect in patients with myelodysplastic syndromes (MDS) has not been studied systematically.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP193508.RACuWyfVLgNIBPBugvpVlYtND_eT4qYlEdUFOGAxp-jP4130_provenance.
- NP515289.RAq_YXWFxdzkLN2vU59894Oc69rf05-g5o5L3_9Hkdams130_assertion description "[Overexpression of MN1, ERG, BAALC, and EVI1 (MEBE) genes in cytogenetically normal acute myeloid leukemia (AML) patients is associated with poor prognosis, but their prognostic effect in patients with myelodysplastic syndromes (MDS) has not been studied systematically.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515289.RAq_YXWFxdzkLN2vU59894Oc69rf05-g5o5L3_9Hkdams130_provenance.
- NP419248.RAK1B3mgB7_7fNj-gyCVuJnm68K_hV0F8eOaXPLI9M248130_assertion description "[Overexpression of MN1, ERG, BAALC, and EVI1 (MEBE) genes in cytogenetically normal acute myeloid leukemia (AML) patients is associated with poor prognosis, but their prognostic effect in patients with myelodysplastic syndromes (MDS) has not been studied systematically.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419248.RAK1B3mgB7_7fNj-gyCVuJnm68K_hV0F8eOaXPLI9M248130_provenance.
- NP673985.RAvSRx_N_hU9u9A0U0r3JQgq_NHQiYCHog4LWlCS-ZvlQ130_assertion description "[Overexpression of MN1, ERG, BAALC, and EVI1 (MEBE) genes in cytogenetically normal acute myeloid leukemia (AML) patients is associated with poor prognosis, but their prognostic effect in patients with myelodysplastic syndromes (MDS) has not been studied systematically.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP673985.RAvSRx_N_hU9u9A0U0r3JQgq_NHQiYCHog4LWlCS-ZvlQ130_provenance.
- assertion description "[Overexpression of MN1, ERG, BAALC, and EVI1 (MEBE) genes in cytogenetically normal acute myeloid leukemia (AML) patients is associated with poor prognosis, but their prognostic effect in patients with myelodysplastic syndromes (MDS) has not been studied systematically.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Overexpression of MN1, ERG, BAALC, and EVI1 (MEBE) genes in cytogenetically normal acute myeloid leukemia (AML) patients is associated with poor prognosis, but their prognostic effect in patients with myelodysplastic syndromes (MDS) has not been studied systematically.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Overexpression of MN1, ERG, BAALC, and EVI1 (MEBE) genes in cytogenetically normal acute myeloid leukemia (AML) patients is associated with poor prognosis, but their prognostic effect in patients with myelodysplastic syndromes (MDS) has not been studied systematically.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Overexpression of MN1, ERG, BAALC, and EVI1 (MEBE) genes in cytogenetically normal acute myeloid leukemia (AML) patients is associated with poor prognosis, but their prognostic effect in patients with myelodysplastic syndromes (MDS) has not been studied systematically.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Overexpression of MN1, ERG, BAALC, and EVI1 (MEBE) genes in cytogenetically normal acute myeloid leukemia (AML) patients is associated with poor prognosis, but their prognostic effect in patients with myelodysplastic syndromes (MDS) has not been studied systematically.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP946632.RAMQwxCrkIvL7JoVigRsm5UzP7TSBf1f9EZKRHSbvm6XY130_assertion description "[Overexpression of MN1, ERG, BAALC, and EVI1 (MEBE) genes in cytogenetically normal acute myeloid leukemia (AML) patients is associated with poor prognosis, but their prognostic effect in patients with myelodysplastic syndromes (MDS) has not been studied systematically.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946632.RAMQwxCrkIvL7JoVigRsm5UzP7TSBf1f9EZKRHSbvm6XY130_provenance.
- NP973491.RAuR95pufHb1T8Sv3ent8NNFFszcdxuZ-UlyL8jpUGUKQ130_assertion description "[Overexpression of MN1, ERG, BAALC, and EVI1 (MEBE) genes in cytogenetically normal acute myeloid leukemia (AML) patients is associated with poor prognosis, but their prognostic effect in patients with myelodysplastic syndromes (MDS) has not been studied systematically.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973491.RAuR95pufHb1T8Sv3ent8NNFFszcdxuZ-UlyL8jpUGUKQ130_provenance.